ENPP3

ENPP3 詳細

英語名Ectonucleotide pyrophosphatase/phosphodiesterase family member 3市販薬剤の数0
治験薬の数4ターゲットの別称EC:3.1.4.1,E-NPP 3,PD-Ibeta,NPPase,CD203c,PDNP3,Phosphodiesterase I/nucleotide pyrophosphatase 3,Nucleotide diphosphatase,ENPP3,DJ914N13.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),Phosphodiesterase-I Beta,Phosphodiesterase I Beta,CD203c Antigen,Gp130RB13-6,NPP3,B10,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3,Ectonucleotide Pyrophosphatase/Phosphodiesterase 3,DJ1005H11.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),EC:3.6.1.9
研究&開発段階Phase 1 Clinical
英語名Ectonucleotide pyrophosphatase/phosphodiesterase family member 3
ターゲットの別称EC:3.1.4.1,E-NPP 3,PD-Ibeta,NPPase,CD203c,PDNP3,Phosphodiesterase I/nucleotide pyrophosphatase 3,Nucleotide diphosphatase,ENPP3,DJ914N13.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),Phosphodiesterase-I Beta,Phosphodiesterase I Beta,CD203c Antigen,Gp130RB13-6,NPP3,B10,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3,Ectonucleotide Pyrophosphatase/Phosphodiesterase 3,DJ1005H11.3 (Phosphodiesterase I/Nucleotide Pyrophosphatase 3),EC:3.6.1.9
市販薬剤の数0
治験薬の数4
研究&開発段階Phase 1 Clinical

ENPP3バックグランド

The human NPP family contains seven members which can be classified into two groups according to their substrate preferences. The first class comprises the nucleotide-degrading proteins NPP1, 3 and 4. NPP3 (CD203c, ENPP3) is expressed in multiple organs, including on epithelial and mucosal surfaces, and notably on basophils and mast cells. Activation of basophils by antigen-bound IgE leads to release of inflammatory mediators and rapid upregulation of NPP3 to the cell surface. This protein is in fact a common marker for diagnosing allergen sensitivity with patient basophils by flow cytometry. Basophils and mast cells mediate the response to certain pathogens, as well as acute and chronic allergic reactions. Following activation, these cells release ATP, which further stimulates them in an autocrine manner. NPP3 upregulation serves to degrade ATP and suppress chronic allergic inflammation (but not the acute response).

ENPP3分子の別称

ENPP3,CD203c,NPP3,E-NPP3,PD-Ibeta,NPPase,PDNP3

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
XmAb-819XmAb-819Phase 1 ClinicalXencor IncCarcinoma, Renal Cell; Kidney Neoplasms
詳細
JNJ-89862175JNJ-89862175Phase 1 ClinicalJanssen Research & Development LlcSolid tumours
詳細
ALY-301ALY-301; GTX-B001Phase 1 ClinicalAlys Pharmaceuticals IncChronic Urticaria; Symptomatic Dermographism; Urticaria
詳細
JNJ-87890387JNJ-87890387Phase 1 ClinicalJanssen Research & Development LlcNeoplasms; Solid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報